Schedule 13D ownership disclosure

PMV PHARMACEUTICALS INC

COMMON STOCK · CUSIP: 69353Y103

Event date: 2026-03-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ORBIMED ADVISORS LLCReported CIK 0001055951

    Shares: 0.00 · Class: 0%

  • ORBIMED CAPITAL GP V LLCReported CIK 0001615374

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-26-000231
Form type
SCHEDULE 13D/A
Filer
ORBIMED ADVISORS LLC
CIK
CIK 1055951
Filed
Mar 04, 2026
Reporting period
Mar 02, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub